Phone: 959-333-0983
Phone: 959-333-0983
$54.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
$54.99
Synthetic GHRH (growth hormone-releasing hormone) analog, the shortest fully functional fragment of GHRH — lyophilized powder. Supplied by Research Chemical exclusively for laboratory research use.
Lyophilized powder, sterile glass vial.
Independently analyzed by an accredited third-party lab.
29-amino-acid GHRH(1-29) fragment, confirmed by mass spectrometry.
Supplied exclusively for laboratory investigation.
| Compound Class | Synthetic GHRH Analog (GHRH 1-29 Fragment) |
|---|---|
| Form | Lyophilized powder, sterile glass vial |
| Amount per Vial | 5 mg |
| Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| CAS Number | 86168-78-7 |
| Chemical Formula | C149H246N44O42 |
| Molar Mass | 3357.9 g/mol |
| Synonyms | Sermorelin, GHRH (1-29), GRF (1-29) |
| Verified Purity | Batch-tested to 98% (HPLC) |
For laboratory research use only. Not for human or animal consumption.
Each peptide batch is analyzed by an accredited third-party laboratory before it ships.
Most recent batch certificate of analysis, issued by MZ Biolabs. Click to view full size on the certificates page.
Every batch sold by Research Chemical is independently analyzed before it ships.
This product is an investigational compound and is not a drug, food, dietary supplement, or cosmetic. It is not approved for human or animal use, and it is unlawful to market it for that purpose.
Sermorelin is a GHRH analog, prohibited by the World Anti-Doping Agency (WADA) at all times under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics).
Research Chemical makes no representations regarding the safety or effects of this compound in humans or animals.
Research Chemical is a chemical supplier, not a medical provider. We do not condone or encourage consumer use of research compounds.
Research use only. All products sold by Research Chemical are intended exclusively for laboratory research and development. They are not for human or animal consumption. These statements have not been evaluated by the U.S. Food and Drug Administration, and these products are not intended to diagnose, treat, cure, or prevent any disease.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
Sermorelin is:
The information provided on this page is for educational and informational purposes only and should not be interpreted as medical advice. ResearchChemical.com assumes no liability for misuse, improper handling, or use outside of controlled research environments. It is the purchaser’s responsibility to ensure compliance with all applicable laws and regulations.
1. Walker, R. F. (2006). Sermorelin: A better approach to management of adult-onset growth hormone insufficiency?. Clinical interventions in aging, 1(4), 307-308.
2. Prakash, A., & Goa, K. L. (1999). Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs, 12, 139-157.
3. Ishida, J., Saitoh, M., Ebner, N., Springer, J., Anker, S. D., & von Haehling, S. (2020). Growth hormone secretagogues: history, mechanism of action, and clinical development. JCSM Rapid Communications, 3(1), 25-37.
4. FARER, L. J. Sermorelin─ a Superior Approach to Growth Hormone Restoration.
5. Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., … & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149.
6. Chang, Y., Huang, R., Zhai, Y., Huang, L., Feng, Y., Wang, D., … & Hu, H. (2021). A potentially effective drug for patients with recurrent glioma: Sermorelin. Annals of Translational Medicine, 9(5).
7. Walker, R. Growth Hormone Releasing Peptides.
8. Friedman, S. D., Baker, L. D., Borson, S., Jensen, J. E., Barsness, S. M., Craft, S., … & Vitiello, M. V. (2013). Growth Hormone–Releasing Hormone effects on brain γ-Aminobutyric acid levels in mild cognitive impairment and healthy aging. JAMA neurology, 70(7), 883-890.
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.